|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||94.28 / 126.07|
European markets are set for a positive open Tuesday after Asia traders booked their best single-day gains in two weeks.
Actelion shares are on the rise again on reports of a potential counter-bid from France's Sanofi.
Stocks enjoyed another strong day on Wall Street as the financial sector pushed the S&P 500 higher.
The Dow trades at an all-time high Monday as the financial and energy sectors rise.
The Dow trades at an all time high Monday as crude oil climbs higher and markets shrug off potential negative effects of Italy's 'no' vote on its constitutional reform referendum.
Stock futures rise Monday as crude oil continues to climb higher and markets shrug off potential negative effects of Italy's 'no' vote on its constitutional reform referendum.
U.S. stock futures point higher following a decisive win for the 'No' campaign in Italy's constitutional referendum Sunday and the pending resignation of Prime Minister Matteo Renzi.
While a phase III study progresses, Acceleron is searching for different populations of MDS patients where luspatercept might also be effective.
J&J will appeal $1 billion in punitive damages to six people injured by a hip implant. The plaintiffs' lawyer argued two losses in Pinnacle cases should convince J&J to settle.
U.S. stock futures slip and oil prices decline ahead of the U.S. payrolls report for November; Starbucks falls after CEO Howard Schultz announces he will step down in April 2017.
Attorney Mark Lanier: Third MDL bellwether trial sends strong message
Jim Cramer is watching Johnson & Johnson, which may buy a Swiss drugmaker. Cramer says it's important to see how the deal is structured.
European stocks ended Tuesday's session with modest gains, although the FTSE 100 drifted lower amid the global oil selloff.
This stock needs more aggressive buying before it is an outright long.
Here are Tuesday's top research calls, including an upgrade for Pfizer, and downgrades for Goldman Sachs, Johnson & Johnson, Delphi and Darden Restaurants.
Oil prices tumble Tuesday on doubts that OPEC can reach an agreement to cut production; U.S. stock futures point to a mild rebound for Wall Street.
European stocks were mixed across the region but improving U.S. futures prices could turn the Tuesday tide.
Actelion shares traded sharply lower Tuesday following reports it's looking at strategies that would keep it independent from a $17 billion approach from Johnson & Johnson.
U.S. stock futures point lower as crude oil gyrates after Saudi Arabia pulls out of a meeting Monday with Russia and other large non-OPEC producers.
Doug Kass shares his thoughts on the Trump world and how large-cap biotechs are doing.
Johnson & Johnson has some of the world's best-known health and personal care brands, while Actelion manufactures popular treatments for pulmonary arterial hypertension.
This health care stalwart is a rare combination of growth and income. Here's why now's the time to scoop it up.
European markets closed higher for the third week running, led by Johnson & Johnson target Actelion, while oil contractors fell along with the price of Brent crude oil.
Wall Street hit new highs on Friday in a half-day session after the Thanksgiving holiday.
Stocks edge higher on Friday, on track to post another record session, in a quieter session after the Thanksgiving holiday in the U.S.
Stock futures edge higher on Friday, on track to post another record session, in a quieter session after the Thanksgiving holiday.
Target sees a surge in online traffic on Thanksgiving; U.S. stock futures suggest the Dow will open at another record high; J&J reportedly is bidding for Switzerland's Actelion.